Table III.

Significant predictors of 1-year TVR among patients receiving DES

Parameters	Precatheterization model					Procedural model
	OR	95% lower CI	95% upper CI	χ2	P	OR	95% lower CI	95% upper CI	χ2	P
Prior PCI	1.316	1.242	1.395	85.54	<.001	1.352	1.274	1.436	98.61	<.001
Age (per 5 y)	0.935	0.914	0.956	34.44	<.001	0.929	0.908	0.950	42.73	<.001
Insulin-treated diabetes	1.304	1.193	1.425	34.31	<.001	1.252	1.147	1.366	25.39	<.001
Prior CABG	1.183	1.106	1.265	23.77	<.001	1.190	1.109	1.277	23.31	<.001
Cerebrovascular disease	1.176	1.094	1.265	19.35	<.001	1.173	1.091	1.261	18.61	<.001
Non–insulin-treated diabetes	1.137	1.065	1.214	14.88	<.001	1.116	1.046	1.191	10.97	<.001
Presentation with NSTE ACS	1.121	1.053	1.194	12.81	<.001	1.142	1.080	1.208	21.56	<.001
Current CHF	0.852	0.777	0.933	11.78	<.001	0.840	0.767	0.920	14.18	<.001
Dialysis	1.342	1.119	1.609	10.09	.001	1.334	1.112	1.600	9.62	.002
Hypertension	1.131	1.045	1.224	9.25	.002	1.124	1.039	1.217	8.41	.004
NYHA Class II (vs I)	1.076	0.999	1.158	8.42	.038
NYHA Class III (vs I)	1.111	1.030	1.198
NYHA Class IV (vs I)	1.102	1.000	1.213
Current/recent smoker	0.928	0.878	0.981	6.91	.009	0.940	0.889	0.993	4.81	.028
BMI per 5 units (when ≥30)	0.955	0.917	0.994	5.17	.023
2-vessel PCI (vs single)						1.577	1.474	1.686	190.98	<.001
3-vessel PCI (vs single)						1.751	1.416	2.165
LCx PCI (vs LAD)						0.825	0.769	0.886	65.68	<.001
LM PCI (vs LAD)						0.562	0.460	0.687
RCA PCI (vs LAD)						0.818	0.765	0.874
Bifurcation lesion						1.218	1.132	1.311	27.70	<.001
Minimum stent diameter (per mm)						0.712	0.668	0.759	108.59	<.001
Total stent length (per mm)						1.004	1.003	1.006	45.79	<.001